Thalys Medical Technology Group Inc.
603716.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.72B
Close$
$-0.87
105.5% downside
Current Fair Value
105.5% downsideOvervalued by 105.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.72 Billion |
|---|---|
| Enterprise Value | $3.88 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.04 |
| Beta | 1 |
| Outstanding Shares | 219,408,132 |
Return
| Return on Equity | -18.22% |
|---|---|
| Return on Assets | -12.51% |
| Return on Invested Capital | -13.89% |
Valuation & Multiples
| P/E Ratio | -17.3 |
|---|---|
| PEG | 62.99 |
| Price to Sales | 5.25 |
| Price to Book Ratio | 3.94 |
| Enterprise Value to Revenue | 4.64 |
| Enterprise Value to EBIT | -26.6 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Thalys Medical Technology Group Inc.
1,045 employees
CEO: Zheng Wang Thalys Medical Technology Group Inc. is a Chinese enterprise that specializes in providing intensive medical business and operational services. The company, established in 2004, is headquartered in Wuhan, China. It previously operated un...